CA
NZ
UK
AU
IND
US
AbCellera (NASDAQ: ABCL) announced a collaboration with Vertex Pharmaceuticals that includes a $28 1 million upfront cash contribution. The deal also promises additional milestone payments and tiered royalties, expanding the company’s revenue potential.
Agios Pharma is on the verge of releasing earnings that could significantly influence its market trajectory, primarily due to the anticipated performance of its newly introduced drug, Mitapivat. Investors are keenly focused on how initial uptake and the overall reception of the drug will …
Amarin Corporation’s (NASDAQ: AMRN) recent earnings report revealed a second quarter earnings per share (EPS) of $0.04, surpassing the estimated loss of $-0.01. The results, announced on July 29, 2026, reflect early success in Amarin's newly adopted international commercial strategy, particularly through its partnership …
Bausch Health Companies Inc. delivered better-than-expected financial results for the second quarter, reporting an earnings per share (EPS) of $1.26, surpassing analyst estimates of $1.05. This solid performance comes alongside a notable revenue increase, with the company achieving consolidated revenues of $2.85 billion for …
Centene Corp (NYSE: CNC) executed a partial redemption of its 2027 senior notes, reducing the outstanding balance while maintaining a sizable portion of the issuance. The redemption was performed at a price that matches the full face value of the notes, ensuring investors receive …
Dyne Therapeutics, Inc. recorded a net loss of $178.6 million for the second quarter of 2026, reflecting significant investment in clinical programs. The company's strategic focus on upcoming FDA approvals for its therapies positions it for future growth, crucial for investors focused on biotech …
Viatris (NASDAQ:VTRS) has received FDA approval for Gwyn Lo, a once-weekly transdermal combined hormonal contraceptive patch delivering a low dose of estrogen, positioning the product as a discreet, non-invasive, and reversible option for women of childbearing potential. The patch is indicated for women with …
Viking Therapeutics, Inc. (NASDAQ:VKTX) shares declined in pre-market trading despite reporting a smaller-than-expected second-quarter loss, as investors remained focused on the pace of the company's cash burn. Viking is a San Diego-based clinical-stage biopharmaceutical company developing novel, orally available therapies for metabolic and endocrine …
Teladoc Health, Inc. (NYSE:TDOC) shares plunged in pre-market trading after the company reported second-quarter results that missed revenue estimates and issued a sharply reduced full-year outlook. Teladoc is a New York-based global leader in virtual care, providing telehealth services to approximately 94 million members …
Teleflex (NYSE:TFX) has received Biologics License Application approval from the FDA for EZPLAZ Freeze Dried Plasma, marking the first freeze dried plasma product ever licensed by the agency and the first biologics license for a blood component in the company's history. The product is …
Please wait processing your request...